Mirae Asset Global Investments
AGIO icon

Mirae Asset Global Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Mirae Asset Global Investments’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.7K Sell
2,660
-396
-13% -$12K ﹤0.01% 1239
2026
Q1 		$103K Buy
3,056
+222
+8% +$6.29K ﹤0.01% 1173
2025
Q4 		$77.1K Buy
2,834
+588
+26% +$20.6K ﹤0.01% 1306
2025
Q3 		$90.2K Buy
2,246
+9
+0.4% +$339 ﹤0.01% 1234
2025
Q2 		$74.4K Buy
2,237
+320
+17% +$9.7K ﹤0.01% 1187
2025
Q1 		$58K Buy
1,917
+17
+0.9% +$564 ﹤0.01% 1212
2024
Q4 		$63.5K Sell
1,900
-158
-8% -$7.42K ﹤0.01% 1233
2024
Q3 		$93.9K Buy
2,058
+363
+21% +$16.5K ﹤0.01% 1192
2024
Q2 		$73.9K Sell
1,695
-37,553
-96% -$1.36M ﹤0.01% 1182
2024
Q1 		$941K Buy
39,248
+314
+0.8% +$8.41K ﹤0.01% 1571
2023
Q4 		$867K Buy
38,934
+1,437
+4% +$32.2K ﹤0.01% 1691
2023
Q3 		$928K Buy
37,497
+689
+2% +$18.2K ﹤0.01% 1558
2023
Q2 		$1.04M Sell
36,808
-3,261
-8% -$81.1K ﹤0.01% 1538
2023
Q1 		$920K Buy
40,069
+10,684
+36% +$284K ﹤0.01% 1590
2022
Q4 		$825K Buy
29,385
+153
+0.5% +$4.31K ﹤0.01% 1596
2022
Q3 		$827K Buy
29,232
+5,810
+25% +$156K ﹤0.01% 1593
2022
Q2 		$519K Buy
+23,422
New +$529K ﹤0.01% 1731
2021
Q4 		– Sell
-4,713
Closed -$217K – 1569
2021
Q3 		$217K Buy
4,713
+611
+15% +$29.5K ﹤0.01% 1670
2021
Q2 		$226K Buy
+4,102
New +$229K ﹤0.01% 1631

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments's AGIO Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Agios Pharmaceuticals (AGIO) stake by 13% in Q2 2026, selling an estimated $12K and leaving 2,660 shares worth $98.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Mirae Asset Global Investments first reported a position in AGIO in Q2 2021 and has held it in 19 quarters since. The position peaked at $1.04M in Q2 2023. 76 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Mirae Asset Global Investments held 2,660 shares of Agios Pharmaceuticals worth $98.7K as of Q2 2026.
  • Mirae Asset Global Investments sold 396 Agios Pharmaceuticals shares in Q2 2026, an estimated $12K.
  • Agios Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1239 holding.
  • Mirae Asset Global Investments first reported a position in Agios Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • Mirae Asset Global Investments's Agios Pharmaceuticals position peaked at $1.04M in Q2 2023.
  • 76 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.